Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling?
about
The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancerSingle Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and IIIdentification of clinically relevant molecular subtypes in colorectal cancer: the dawning of a new eraA rank-based transcriptional signature for predicting relapse risk of stage II colorectal cancer identified with proper data sources.Cost-effectiveness of aspirin adjuvant therapy in early stage colorectal cancer in older patients.Cancer genomic research at the crossroads: realizing the changing genetic landscape as intratumoral spatial and temporal heterogeneity becomes a confounding factor.Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival.Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision.Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581.Personalized medicine and the clinical laboratory.The role of personalized medicine in metastatic colorectal cancer: an evolving landscape.Validation of the 12-gene colon cancer recurrence score in NSABP C-07 as a predictor of recurrence in patients with stage II and III colon cancer treated with fluorouracil and leucovorin (FU/LV) and FU/LV plus oxaliplatin.A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markersThe Management and Prognostic Prediction of Adenocarcinoma of Appendix.Biomarkers in precision therapy in colorectal cancer.Building personalized treatment plans for early-stage colorectal cancer patients.Promoter CpG island methylation markers in colorectal cancer: the road ahead.Proteomics in studying cancer stem cell biology.Gene expression profile is associated with chemoradiation resistance in rectal cancer.Personalized treatment for patients with colorectal cancer: role of biomarkers.Translating colorectal cancer genetics into clinically useful biomarkers.Lymphovascular invasion is a high risk factor for stage I/II colorectal cancer: a systematic review and meta-analysis.Intra-tumoural stromal morphometry predicts disease recurrence but not response to 5-fluorouracil - results from the QUASAR trial of colorectal cancer.A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal Cancer.A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer.Evolving notions on immune response in colorectal cancer and their implications for biomarker development.
P2860
Q21090644-B6BFACE2-71FB-481F-8F32-BB65714A6FFEQ26765344-CE5363BE-727F-4189-989E-A3EB6726A8ABQ27693248-11B6A5D2-E982-4EC1-8CFA-A79EAF624476Q31056926-496C7669-AF08-4414-842E-1F3F97695F8FQ34251380-9D75FC8E-05B8-486A-B5EC-B07313799469Q34537690-3AC96950-E75A-49FF-9E44-2CAE9BDB394EQ36544364-409C3C15-A743-495F-A314-960E6FD805BEQ36688767-14977A89-FD21-4898-A3D9-D0CAFAA4DA51Q36810728-950D27DE-A4BB-43B7-B2E8-50415E1E295BQ36916966-95F7B119-9CBE-4D68-8CD1-50BE549660FFQ37130603-C8F15728-32D3-45A1-808F-310378C66408Q37411227-3546D3C7-B3BB-4080-BDC3-AB3C7660EE95Q37413869-03CACBC3-CB5F-4C1A-B6ED-9FD27C1DCE01Q37508586-16C2A9C2-BE8E-4BB3-9144-7F55DEE12CD1Q37609130-559FF0BC-D6EC-40BA-AC59-5A695A6E58BFQ37706705-78FEB69A-B417-4EA4-9C57-D771D0F95C39Q37997086-D2132BAD-53CF-4B15-835D-AEB450DFC9D6Q38027219-08C7D80A-6F30-42D4-8678-8FF62CBE97F9Q38137324-47CEB6A2-20B5-4871-87DF-456C9FB3A256Q38390834-9166A17A-AF2A-4E22-9844-55642E24E0D1Q38779895-E223CE85-6240-4A94-B020-8CD7D2B6E77FQ39254722-B29C2FB3-4989-4C0B-AA07-82249ED27119Q40489826-FCD70875-A379-4219-812F-97D46C2E4CB8Q42870388-014E0817-7762-4F6D-AF20-93B58B81FCA9Q47098203-0C6459B0-C3FF-4017-9C5B-6BB84831DDA9Q50098505-FCD4CA49-C372-49ED-890C-5ACA6C4312C8
P2860
Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling?
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Prognostic and predictive mark ...... for gene expression profiling?
@ast
Prognostic and predictive mark ...... for gene expression profiling?
@en
Prognostic and predictive mark ...... for gene expression profiling?
@nl
type
label
Prognostic and predictive mark ...... for gene expression profiling?
@ast
Prognostic and predictive mark ...... for gene expression profiling?
@en
Prognostic and predictive mark ...... for gene expression profiling?
@nl
prefLabel
Prognostic and predictive mark ...... for gene expression profiling?
@ast
Prognostic and predictive mark ...... for gene expression profiling?
@en
Prognostic and predictive mark ...... for gene expression profiling?
@nl
P2860
P3181
P1476
Prognostic and predictive mark ...... for gene expression profiling?
@en
P2093
Alan P. Venook
Robin K. Kelley
P2860
P3181
P356
10.1016/J.CLCC.2011.03.001
P407
P577
2011-06-01T00:00:00Z